Thus, the primary treatment for patients with cognitive impairment is acetylcholinesterase (AChE) inhibitors such as tacrine or donepezil, which increase the availability of acetylcholine at cholinergic synapses9. This evidence concerns the gene ACHE and Cognitive impairment.